Docetaxel-estramustine in localized high-risk prostate cancer: Results of the French Genitourinary Tumor Group GETUG 12 phase III trial.
暂无分享，去创建一个
S. Culine | G. Gravis | Anne-Laure Martin | M. Baciuchka | N. Houédé | C. Théodore | A. Laplanche | K. Fizazi | J. Ferrero | B. Laguerre | I. Krakowski | F. Priou | J. Berdah | M. Habibian | J. Davin | L. Faivre | F. Lesaunier | F. Rolland | L. Mourey | R. Delva